Cancer Genetics Journal

With the rapid evolution of genomic technologies and precision medicine, Cancer Genetics Journal is committed to supporting open scientific dialogue and disseminating innovative findings that contribute to improved cancer prevention strategies, diagnostic accuracy, and targeted therapeutic approaches. Our mission is to support scientific progress by publishing research that connects fundamental discoveries in cancer biology with clinical applications that improve diagnosis, prognosis, and treatment outcomes.

Journal Overview

Cancer is a genetically complex disease driven by a wide range of molecular alterations, including mutations, epigenetic changes, and disruptions in cellular signaling pathways. Cancer Genetics Journal focuses on these mechanisms, publishing research that explores how genetic and genomic factors contribute to cancer initiation and progression.

The journal serves as a bridge between basic science and clinical oncology, encouraging interdisciplinary collaboration among researchers in genetics, bioinformatics, oncology, pharmacology, and systems biology. We welcome contributions from around the world and aim to provide a global platform for scientific exchange in cancer research.

Our Vision

The vision of Cancer Genetics Journal is to become a trusted and influential source of knowledge in cancer genomics and precision medicine. We strive to:

• Promote innovative research in cancer genetics and molecular oncology
• Encourage the integration of genomic data into clinical practice
• Support the development of personalized cancer therapies
• Foster international collaboration among researchers and clinicians
• Advance scientific understanding of cancer heterogeneity and evolution

Through these goals, we aim to contribute meaningfully to the global effort to reduce the burden of cancer.

Scope and Research Focus

The journal publishes research across a wide range of topics within cancer genetics and related disciplines, including:

Molecular Oncology

Studies on the molecular mechanisms underlying tumor growth, metastasis, and resistance to therapy.

Cancer Genomics

High-throughput sequencing studies, genomic profiling, and identification of cancer-associated genetic variants.

Epigenetics and Gene Regulation

Research on DNA methylation, histone modification, chromatin structure, and regulatory non-coding RNAs in cancer.

Biomarker Discovery

Identification and validation of molecular markers for cancer detection, classification, and treatment response.

Precision Oncology

Application of genomic and molecular data to develop targeted therapies and personalized treatment strategies.

Computational Cancer Biology

Use of bioinformatics, machine learning, and systems biology approaches to analyze complex cancer datasets.

For Authors

• Submission guidance: Prepare a structured manuscript with clear objectives, methods, results, and clinical implications. Include high‑quality figures for cytogenetic and molecular data and ensure ethical approvals are documented. Submissions are welcomed across basic, translational, and clinical genetics studies.
• Peer review and timelines: The journal follows standard peer‑review procedures; authors should expect editorial checks followed by external review. Provide suggested reviewers and disclose conflicts of interest.

For Readers and Clinicians

• Why read: The journal bridges laboratory genetics and clinical practice, offering case reports and studies that can inform diagnostic workflows and genetic counseling. Recent issue highlights demonstrate practical diagnostic applications and reports of clinically actionable genomic findings.

Limitations and Notes

• Availability and indexing: Confirm current indexing status and open access policies on the journal’s official pages before submission; indexing and access models can change over time.
• Archival source: This content was prepared using the journal’s archived editorial and issue information to ensure accuracy of scope and article types.

Cancer Genetics Journal provides a trusted platform for high-impact scientific communication in oncology research. We are committed to maintaining high editorial standards and ensuring that all published research contributes meaningfully to the global scientific community.

Key benefits include: